B. Riley Wealth Advisors’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
Other funds holding TCRT
DCM
MP
BC
GCP
CB
B. Riley Wealth Advisors's TCRT Position: Q3 2023 in Review
B. Riley Wealth Advisors sold out of Alaunos Therapeutics (TCRT) in Q3 2023, closing a stake of 77 shares — an estimated $5.93K sold.
B. Riley Wealth Advisors first reported a position in TCRT in Q2 2014 and held it in 14 quarters. The position peaked at $144K in Q3 2017. 89 funds tracked by Wall St. Rank hold TCRT as of Q3 2023.
- B. Riley Wealth Advisors reported no remaining Alaunos Therapeutics position as of Q3 2023 after selling out during the quarter.
- B. Riley Wealth Advisors sold 77 Alaunos Therapeutics shares in Q3 2023, an estimated $5.93K.
- B. Riley Wealth Advisors first reported a position in Alaunos Therapeutics in Q2 2014 and held it in 14 quarters.
- B. Riley Wealth Advisors's Alaunos Therapeutics position peaked at $144K in Q3 2017.
- 89 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2023.
Based on B. Riley Wealth Advisors's 13F filing for Q3 2023, filed 1 Dec 2023.